Q2 2026 saw a 45% YoY increase in adjusted EBITDA to $74.4M and a 126% rise in adjusted net income to $27.1M, driven by broad-based volume growth, margin recovery, and Project Catalyst savings. Surfactants and Polymers segments delivered strong results, while leverage improved to 2.5x.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.